Novartis bags Adakveo FDA approval to reduce VOCs in sickle cell disease

Adakveo FDA approval : Swiss drugmaker Novartis has bagged approval for Adakveo (crizanlizumab-tmca) from the US Food and Drug Administration (FDA) for its use in ... Read More